WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012094600) METHODS FOR TREATING LYSOSOMAL STORAGE DISEASES USING L-TYPE CA2+ CHANNEL BLOCKERS WITH A 1,4 DIHYDROPYRIDINE STRUCTURE AND INHIBITORS OF ER-ASSOCIATED DEGRADATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/094600    International Application No.:    PCT/US2012/020492
Publication Date: 12.07.2012 International Filing Date: 06.01.2012
IPC:
A61K 31/4422 (2006.01)
Applicants: WILLIAM MARSH RICE UNIVERSITY [US/US]; Office Of Technology Transfer MS 705 P.O. Box 1892 Houston, TX 77251-1892 (US) (For All Designated States Except US).
SEGATORI, Laura [IT/US]; (US) (For US Only).
WANG, Fan [CN/US]; (CN) (For US Only)
Inventors: SEGATORI, Laura; (US).
WANG, Fan; (CN)
Agent: THOMAS, Lisa Maria; Baker Botts LLP 910 Louisiana Street Houston, TX 77002 (US)
Priority Data:
61/430,326 06.01.2011 US
Title (EN) METHODS FOR TREATING LYSOSOMAL STORAGE DISEASES USING L-TYPE CA2+ CHANNEL BLOCKERS WITH A 1,4 DIHYDROPYRIDINE STRUCTURE AND INHIBITORS OF ER-ASSOCIATED DEGRADATION
(FR) PROCÉDÉS DE TRAITEMENT DE MALADIES LYSOSOMALES À L'AIDE DE BLOQUEURS DE CANAUX CALCIQUES DE TYPE L AYANT UNE STRUCTURE DE 1,4-DIHYDROPYRIDINE ET D'INHIBITEURS DE LA DÉGRADATION ASSOCIÉE AU RÉTICULUM ENDOPLASMIQUE (ER)
Abstract: front page image
(EN)Methods are provided for the treatment of lysosomal storage diseases, such as Gaucher's disease. In one embodiment, a method comprising administering to a subject a therapeutically effective amount of a L-type Ca2+ channel blocker with a 1,4 dihydropyridine structure is provided.
(FR)L'invention porte sur des procédés pour le traitement de maladies lysosomales, telles que la maladie de Gaucher. Dans un mode de réalisation, l'invention porte sur un procédé qui consiste à administrer à un sujet une quantité thérapeutiquement efficace d'un bloqueur des canaux calciques de type L ayant une structure de 1,4-dihydropyridine.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)